Spinális izomatrófia (SMA): vizsgálatok itt: Japán
2 of 4 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam
- Where
- Toyonaka
- Életkor
- 15 év to 60 év
- People
- 90 worldwide
- Run by
- Biogen
See details and how to joinNCT07444476 - 3. fázisTaking peopleA Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
- Where
- Tokyo
- Életkor
- 0 nap to 42 nap
- People
- 30 worldwide
- Run by
- Biogen
See details and how to joinNCT07221669 · EU 2025-524054-34-00